Clalit Health Services unit Mor Research Applications has backed Aspire Venture Precision Medicine Fund and partnered its Smart Health Innovation Lab.
Mor Research Applications, a subsidiary of Israel-based insurance provider and hospital operator Clalit Health Services, has provided an undisclosed amount of capital for US-based private equity firm Aspire Universal’s latest fund.
Aspire launched Aspire Venture Precision Medicine Fund in April 2018 with $30m to invest in medical devices and therapies that leverage artificial intelligence and internet-of-things technology. The vehicle will be co-managed by healthcare services provider Penn Medicine Lancaster General Health.
The fund also supports technology emerging from the Smart…
